Taiwan
· Delayed Price · Currency is TWD Johnson Chemical Pharmaceutical Works Statistics
Total Valuation
Johnson Chemical Pharmaceutical Works has a market cap or net worth of TWD 3.11 billion. The enterprise value is 2.16 billion.
| Market Cap | 3.11B |
| Enterprise Value | 2.16B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | Jun 21, 2024 |
Share Statistics
Johnson Chemical Pharmaceutical Works has 44.93 million shares outstanding. The number of shares has increased by 50.87% in one year.
| Shares Outstanding | 44.93M |
| Shares Change (YoY) | +50.87% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 19.96% |
| Owned by Institutions (%) | n/a |
| Float | 35.96M |
Valuation Ratios
The trailing PE ratio is 38.33.
| PE Ratio | 38.33 |
| Forward PE | n/a |
| PS Ratio | 4.84 |
| PB Ratio | 1.87 |
| P/FCF Ratio | 35.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.93, with an EV/FCF ratio of 24.89.
| EV / Earnings | 27.69 |
| EV / Sales | 3.50 |
| EV / EBITDA | 18.93 |
| EV / EBIT | 23.30 |
| EV / FCF | 24.89 |
Financial Position
The company has a current ratio of 5.34, with a Debt / Equity ratio of 8.99.
| Current Ratio | 5.34 |
| Quick Ratio | 4.81 |
| Debt / Equity | 8.99 |
| Debt / EBITDA | 1.31 |
| Debt / FCF | 1.73 |
| Interest Coverage | 17.76 |
Financial Efficiency
Return on equity (ROE) is 6.06% and return on invested capital (ROIC) is 3.67%.
| Return on Equity (ROE) | 6.06% |
| Return on Assets (ROA) | 3.28% |
| Return on Capital (ROIC) | 3.67% |
| Revenue Per Employee | 3.69M |
| Profits Per Employee | 465,988 |
| Employee Count | 167 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.39% in the last 52 weeks. The beta is -0.36, so Johnson Chemical Pharmaceutical Works's price volatility has been lower than the market average.
| Beta (5Y) | -0.36 |
| 52-Week Price Change | -31.39% |
| 50-Day Moving Average | 69.48 |
| 200-Day Moving Average | 76.36 |
| Relative Strength Index (RSI) | 49.89 |
| Average Volume (20 Days) | 33,648 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Johnson Chemical Pharmaceutical Works had revenue of TWD 616.34 million and earned 77.82 million in profits. Earnings per share was 1.81.
| Revenue | 616.34M |
| Gross Profit | 244.74M |
| Operating Income | 92.52M |
| Pretax Income | 97.84M |
| Net Income | 77.82M |
| EBITDA | 113.87M |
| EBIT | 92.52M |
| Earnings Per Share (EPS) | 1.81 |
Balance Sheet
The company has 1.11 billion in cash and 149.44 million in debt, giving a net cash position of 958.37 million or 21.33 per share.
| Cash & Cash Equivalents | 1.11B |
| Total Debt | 149.44M |
| Net Cash | 958.37M |
| Net Cash Per Share | 21.33 |
| Equity (Book Value) | 1.66B |
| Book Value Per Share | 36.99 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 116.53 million and capital expenditures -29.93 million, giving a free cash flow of 86.61 million.
| Operating Cash Flow | 116.53M |
| Capital Expenditures | -29.93M |
| Free Cash Flow | 86.61M |
| FCF Per Share | 1.93 |
Margins
Gross margin is 39.71%, with operating and profit margins of 15.01% and 12.63%.
| Gross Margin | 39.71% |
| Operating Margin | 15.01% |
| Pretax Margin | 15.87% |
| Profit Margin | 12.63% |
| EBITDA Margin | 18.48% |
| EBIT Margin | 15.01% |
| FCF Margin | 14.05% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 2.16%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 2.16% |
| Dividend Growth (YoY) | -25.08% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 77.15% |
| Buyback Yield | -50.87% |
| Shareholder Yield | -48.71% |
| Earnings Yield | 2.61% |
| FCF Yield | 2.78% |
Stock Splits
The last stock split was on July 30, 2014. It was a forward split with a ratio of 1.125.
| Last Split Date | Jul 30, 2014 |
| Split Type | Forward |
| Split Ratio | 1.125 |